Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene

  • Jordi Sunyer1, 2Email author,
  • Carmen Herrero3,
  • Dolores Ozalla3,
  • Maria Sala1,
  • Núria Ribas-Fitó1,
  • Joan Grimalt4 and
  • Xavier Basagaña1
Environmental Health20021:1

DOI: 10.1186/1476-069X-1-1

Received: 17 June 2002

Accepted: 19 July 2002

Published: 19 July 2002



Porphyria cutanea tarda (PCT) is caused by hexachlorobenzene (HCB) in several species of laboratory mammals, but the human evidence is contradictory. In a study among adults of a population highly exposed to HCB (Flix, Catalonia, Spain), the prevalence of PCT was not increased. We aimed at analysing the association of individual urinary porphyrins with the serum concentrations of HCB and other organochlorine compounds in this highly exposed population.


A cross-sectional study on total porphyrins was carried out in 1994 on 604 inhabitants of the general population of Flix, older than 14 years. Of them, 241 subjects (comprising a random sample and the subgroup with the highest exposure) were included for the present study. The porphyrin profile was determined by high-pressure liquid chromatography. Serum concentrations of HCB, as well as common organochlorine compounds, were determined by gas chromatography coupled to electron capture detection.


Coproporphyrin I (CPI) and coproporphyrin III (CPIII) were the major porphyrins excreted, while uroporphyrins I and III were only detected in 2% and 36% of the subjects respectively, and heptaporphyrins I and III in 1% and 6%, respectively. CPI and CPIII decreased with increasing HCB concentrations (p < 0.05). This negative association was not explained by age, alcohol, smoking, or other organochlorine compounds. No association was found between uroporphyrin I and III excretion, nor heptaporphyrin excretion, and HCB. CPIII increased with smoking (p < 0.05).


HCB exposure in this highly exposed population did not increase urinary concentrations of individual porphyrins.


coproporphyrin I coproporphyrin III hexachlorobenzene organochlorinated compounds porphyria uroporphyrin

The porphyrias are disorders of the haem biosynthesis in which specific patterns of overproduction of haem precursors are associated with particular clinical features. Porphyria cutanea tarda (PCT) is one of the major potential toxic manifestations of hexachlorobenzene (HCB) in several species of laboratory mammals [1]. However, the porphyrinogenic effect of this chemical on humans has not been widely studied. The first cases of PCT induced by HCB in humans were reported in south-eastern Turkey in the late 1950s due to food poisoning in undernourished children [24]. Levels of HCB were not measured. In addition, there have been some case reports of workers exposed to HCB developing PCT [5], but there was no association between exposure to HCB and PCT in small studies in workers [68].

High atmospheric levels of HCB (mean 35 μg/m3) were detected in Flix (Catalonia, Spain), a village of 5,000 inhabitants located in the vicinity of an electrochemical factory, the only industry in town [9]. Internal dose concentrations (i.e., serum) found were the highest ever reported in human general populations [10]. In a survey of 604 inhabitants only one subject had abnormally high levels of total porphyrins, compatible with PCT [11], resulting in a prevalence of PCT not higher than expected [12]. The association between individual urinary porphyrins and the internal dose of HCB was studied only in the 15 subjects with extremely high levels of HCB. Although concentrations of total porphyrins were within the range of clinical normality in this adult population [11], variations within the normality could be informative of subclinical harmful effects (i.e., functional effects). In addition, functional effects may be applied to risk assessment and prevention for its potential impact on susceptible populations [13].

Our objective was to determine the association between individual urinary porphyrin levels and serum concentrations of HCB and other organochlorine compounds in the general population of Flix.

Material & Methods

Study population

An epidemiological cross-sectional study was carried out on the 4,178 inhabitants of Flix older than 14 years in 1994 and details of participation and sociodemographic characteristics are described elsewhere [14]. Total porphyrins were analysed in 604 of these participants [11], a subsample of 241 of them being included in the present study. This subsample was composed of a 100 subjects previously selected for the studies of HCB biokinetics [15] consisting of those 8 subjects with the four highest and four lowest HCB levels, complemented by a random sample of 92, supplemented by a further 141 subjects who had worked in the electrochemical factory. Workers were included because they had the highest levels of HCB in Flix [10]. In total, 177 out of the 241 subjects had worked in the electrochemical factory at some time, of whom 55 were currently employed. The individual with PCT was excluded from this analysis. All subjects were informed of the purpose of the study and signed a written consent form approved by the ethical committee at IMIM.

Urinary porphyrin measurements

Urine samples (24 h) were collected in 2 L plastic flasks. Immediately after collection, sodium bicarbonate was added to obtain a solution of 5 g/L, and 5 ml aliquots were transferred to polypropylene tubes and stored at -20°C until analysis. All urine specimens were analysed without previous knowledge of HCB levels in serum. Urinary porphyrin excretion patterns were analysed by high performance liquid chromatography (HPLC). Briefly, 1 mL of urine sample was acidified with 50 μL of HCl and 200 μL of this solution was injected. The HPLC determination was performed with Waters equipment (Waters Corp. Mildford, MA, USA) (2 pumps mod. 515, an autosampler injector (mod. 717 plus) and Millennium software). The porphyrins were detected using a fluorescence detector (mod. 474), under the following conditions: excitation 405 nm, emission 618 nm, both with band widths of 18 nm. Porphyrin separation was achieved with an analytical column BDS-Hypersil (250 × 4.6 mm, 5 μm particle size) (Shandon HPLC, Cheshire, U.K) and a gradient from 100% of solvent A (10:90 acetonitrile/ammonium acetate 1 M pH 5.16) to 95% of solvent B (10:90 acetonitrile/methanol) in 25 min. The flow rate was 1.2 mL/min [16].

Analysis of organochlorine compounds

Organochlorine compounds in serum were analysed by gas chromatography (GC) coupled to electron capture detection and GC coupled to chemical ionisation negative-ion mass spectrometry. A Varian Star 3400 coupled to a Finnigan Mat INCOS XL was used for the analyses. All the analyses were carried out in the Department of Environmental Chemistry (CID-CSIC). Details of the methodology have been reported elsewhere [10, 15]. We present results for the most prevalent compounds found in sera samples: HCB, dichlorodiphenyl dichloroethene (p,p'-DDE), and polychlorinated biphenyls (PCBs) which we present as the summation of the individual congeners 28, 52, 101, 118, 138,153, and 180. Because the PCB congeners 138, 153 and 180 represented around 90% of total PCBs, we also provide results of these individual congeners. Detection limits for HCB and p,p'-DDE were 0.2 ng/mL, and for the individual congeners of PCBs were the following: 0.17, 0.15, 0.09, 0.11, 0.15, 0.12, and 0.10. The concentration of organochlorine compounds below the detection limit were set at half the limit of detection.

Statistical analysis

Individual porphyrins were treated both as a dichotomous variable (detectable/non-detectable) and as continuous variable after assigning half the detectable level to represent the non-detectable values. Total porphyrins were analysed only as a continuous variable since all observations were detectable, while uroporohyrins were analysed only as a dichotomous variable since most of the observations were not-detectable. The crude association between porphyrins and the study variables (organochlorine compounds as well as confounding variables such age, sex, alcohol, smoking and duration of the residence) was assessed with the non-parametric Wilcoxon test for linear trend, given the non-normal distribution of porphyrins. To control the association between porphyrins and organochlorine compounds for the confounding variables both linear regression models and logistic regression models were fitted. Since the data distribution of individual porphyrins was skewed, a logarithmic transformation was carried out. Organochlorine compounds were treated both as trichotomous variables and as continuous variables, given a certain linearity in the association with porphyrins. Organochlorine compounds were also logarithmically transformed (in base 10) to achieve a normal distribution. Multiple linear regression analysis was performed to examine the relationship between continuous values of porphyrins (total porphyrins, CP I, CPIII) and organochlorine levels adjusting for potential confounding variables such as creatinine in serum [14]. Association was measured with the regression coefficient. The antilogarithm of the coefficient yields the relative change in porphyrin levels for each 10-fold increase in organochlorine compound levels. Multiple logistic regression models were fitted to estimate the adjusted association between categorical values of uroporophyrins I and III and organochlorine compounds. The measure of association was the odds ratio. Statistical significance was defined as p < 0.05. All statistical analyses were performed using Stata (StataCorp. TX, USA).


Table 1 presents the socio-demographic and behavioural characteristics of the subjects included in this study. Not surprisingly, most of them are males given that we enriched the sample with the electrochemical workers in order to have the individuals with the highest HCB levels in the study. It is noticeable that most of them had lived in the town for more than 20 years.
Table 1

Characteristics of the 241 subjects


n (%)


180 (75)



   < 45 years

89 (37)

   45–64 years

84 (35)

   > 64 years

68 (28)




73 (30)


61 (25)

   Habitual (> 3 drinks a week)

107 (45)




73 (30)


11 (5)


82 (34)


75 (31)

<20 cigs./day

33 (13)

≥ 20 cigs./day

42 (18)

Years living in Flix



4 (2)


19 (8)


218 (90)

Distributions of total porphyrin concentrations and individual urinary porphyrins as well as organochlorine compound levels in serum are presented in table 2. Coproporphyrin isomers I-III (CPI; CPIII) were the major porphyrins excreted. The uroporphyrin I (UPI) fraction was the third most excreted porphyrin. The heptacarboxylporphyrin isomer I (hepta I) was only detected in 1% of subjects and the heptaporphyrin isomer III (hepta III) in 6%. The hexa- and pentacarboxylporphyrin fractions were not detected. Among the organochlorine compounds, all subjects had detectable concentrations of HCB, and most of them of p,p'-DDE. The highest concentrations were found for HCB. The most prevalent PCB congener was CB-180.
Table 2

Distribution of urinary uroporphyrines (μmol/L) and serum concentrations of organochlorinated compounds (ng/mL) (n = 241 subjects)


% detectable

Percentiles among detectables







Total porphyrins







   Uro I







   Uro III







   Hepta I







   Hepta III







   Copro I







   Copro III





















Total PCBs†




























Uro: uroporphyrins; Hepta: heptaporphyrins; Copro: coproporphyrins. † PCBs = Σ (28, 52, 101, 118, 138, 153, 180) congeners

Total porphyrins decreased with age, years of residence in Flix, and organochlorine concentrations (except CB-153) and increased with male gender and tobacco smoking, in a statistically significant way, while no association was observed with alcohol consumption (table 3). A similar pattern was observed with CPI and CPIII, except that the association with sex disappeared. However, for CPI the only statistically significant differences found were for age, years of residence, HCB and p,p'-DDE, but not for smoking or PCBs. For CPIII, the associations with smoking and PCBs, in addition to age, years of residence, HCB and p,p'-DDE, were significant. The negative association of CPI and CPIII with HCB occurred both in subjects working in the electrochemical factory (with the highest HCB levels, median of HCB = 79.2 ng/mL) and in non-workers (median HCB = 14.2 ng/mL). Workers had lower average levels of CPIII than non-workers (20.6 and 33.3 μmol/L, respectively) and of CPI (6.8 and 11.2 μmol/L, respectively) (all p < 0.05). UPI and UPIII did not differ for any of the study variables (table 3), and nor did heptaporphyrin.
Table 3

Association between urinary porphyrine concentrsations and the study variables (age, sex, alcohol, smoking, years of residence, and organochlorintaed compounds in serum).



Copro I

Copro III

Uro I + UroIII


Median (25%–75%)

Detectables n (%)

Median (25%-75%) †

Detectables n (%)

Median (25%-75%) †

Detectables n (%)




117 (73–185)

70 (79)

7 (3–15)

85 (96)

29 (11–46)

31 (35)


89 (62–132)

62 (74)

4 (0.5–8)

67 (80)

14 (4.5–27.5)

24 (29)


83 (56–126)*

51 (75)

4 (1.3–9)*

56 (82)*

12.5 (3–30)*

27 (40)




85 (62–112)

42 (69)

5 (0.5–11)

60 (98)

20 (10–31)

17 (28)


107 (65–165)*

141 (78)

5 (2–11)

148 (82)*

19 (5–37)

65 (36)




99 (62–144)

52 (71)

5 (0.5–11)

67 (92)

18 (6–35)

23 (32)


86 (64–143)

45 (74)

5 (0.5–10)

52 (85)

19 (7–35)

21 (34)


103 (66–162)

86 (80)

5 (3–12)

89 (83)

20 (5–35)

38 (36)




86 (62–124)

52 (71)

5 (0.5–10)

64 (88)

19 (6–29)

19 (26)

   Ocasional + Ex

92 (60–146)

65 (70)

4 (0.5–10)

76 (82)

12 (4–35)

33 (35)

   < 20 cigs./day

103 (83–159)

30 (91)

6 (4–9)

28 (85)

20 (7–39)

12 (36)

   ≥ 20 cigs./day

127 (81–588)*

36 (86)*

6.5 (3.5–15)

40 (95)

32 (12–46)*

18 (43)

Years living in Flix


   ≤ 20 years

165 (86, 240)

21 (91)

7 (3, 19)

22 (95)

27 (17,51)

10 (43)

   > 20 years

94 (62, 143)*

162 (74)

5 (0.5, 10)*

186 (85)

19 (6, 34)*

72 (33)

HCB ng/ml (tertiles)



129 (81–176)

60 (77)

7 (2–15)

73 (94)

26 (8–43)

29 (37)


82 (55–126)

62 (75)

4 (0.5–10)

70 (84)

18 (5–31)

28 (34)


92 (64–130)*

61 (76)

5 (2–8.5)*

65 (81)*

14 (5–31.5)*

25 (31)

DDE ng/ml (tertiles)


   < 3.22

124 (74–179)

62 (78)

7 (2–15)

74 (94)

26 (7–49)

31 (39)

   3.22 – 9.88

105 (65–161)

60 (75)

4 (0.5–10)

64 (80)

20 (4.5–35)

22 (28)

   > 9.88

82 (57–117)*

61 (74)

5 (2–8.5)*

70 (85)

12 (5–26)*

29 (35)

PCBs ng/ml (tertiles)


   < 2.08

108 (74, 166)

63 (80)

6 (2–13)

72 (91)

22 (7, 35)

21 (27)


99 (61, 172)

60 (77)

4 (2–12)

69 (88)

20 (6, 38)

30 (38)

   > 4.89

87 (59, 130)*

60 (73)

4.5 (0.5–9)

67 (80)*

13.5 (4, 30)*

31 (37)

CB-138 (tertiles)


   < 0.55

108 (73–116)

63 (79)

5.5 (2.5–13)

73 (91)

20 (7.5–36.5)

19 (24)

   0.55 – 1.29

99 (61–146)

63 (80)

5 (2–12)

69 (87)

21 (6–38)

36 (46)

   > 1.29

89 (60–130)*

57 (70)

4 (0.5–9)

66 (80)*

13 (4–29)*

27 (33)

CB-153 (tertiles)


   < 0.61

109 (73–161)

65 (81)

6 (3–13.5)

74 (93)

21 (8.5–35)

21 (26)

   0.61 – 1.36

98 (61–173)

58 (73)

4 (0.5–11)

66 (84)

20 (5–39)

30 (38)

   > 1.36

87 (61–130)

60 (73)

4 (0.5–9)*

68 (83)

13 (5–32)

31 (38)

CB-180 (tertiles)


   < 0.61

110 (73–168)

64 (80)

5 (2–11.5)

72 (90)

21 (7–38.5)

22 (28)

   0.61 – 1.80

94 (61–143)

59 (75)

5 (0.5–12)

73 (92)

20 (6–37)

26 (33)

   > 1.80

90 (60–141)*

60 (73)

4.5 (0.5–10)

63 (77)*

14 (3–29)*

34 (41)

TP: total porphyrins; CPI, CPIII: coproporphyrins I, III; UPI, UPIII: uroporphyrins I, III. * p < 0.05 using the extension of the non-parametric Wilcoxon test for linear trend † non-detectable values were set at the median value between 0 and the detectable level

The negative association of HCB with total porphyrins and CPIII remained after adjusting for the confounding variables (table 4). The association between HCB and CPI was also negative but with a p value of 0.06. When HCB was treated as a trichotomous variable in the multivariate models, results were very similar to those in table 3 (where they were unadjusted), with a p value < 0.05 for CPIII. In contrast, the associations of p,p'-DDE and PCBs disappeared in the multivariate model. HCB remained associated with total porphyrins and CPIII after adjusting for p,p'-DDE and PCBs. In the multivariate models, the positive associations of smoking with total porphyrins (coefficient (se) = 0.18 (0.08)), and mainly with CPIII (coefficient (se) = 0.30 (0.13)) remained, and so did the negative association of age with total porphyrins, CPI and CPIII. The adjusted association with UPI and UPIII remained non-significant.
Table 4

Adjusted association between urinary porhyrin levels and serum concentrations of organochlorinated compounds (n = 241).

Organochlorinated compound


Copro I

Copro III


Coefficient (se)†

Single pollutant model



-0.265 (0.078)*

-0.321 (0.171)

-0.395 (0.187)*


-0.024 (0.049)

0.048 (0.115)

-0.051 (0.123)


-0.005 (0.048)

-0.039 (0.111)

-0.019 (0.120)

Multipollutant model††



-0.281 (0.079)*

-0.315 (0.174)

-0.420 (0.190)*


-0.056 (0.053)

0.039 (0.127)

-0.092 (0.137)


0.005 (0.052)

-0.059 (0.121)

-0.011 (0.131)

TP: Total porphyrins. CPI and CPIII: coproporphyrins, I and III, respectively. † The coefficient gives the relative change in prophyrin levels for a 10-fold concentration increase in the organochlorinated compound., adjusted for age, smoking, alcohol, years of residence in Flix, and creatinine in serum. †† Adjusted for age, smoking, alcohol and years of residence in Flix, as well as for the other organochlorinated compounds in the table. * p < 0.05


In experimental porphyria in laboratory animals, intake of HCB was followed initially by a moderate increase of coproporphyrins, and later by an increase of highly carboxylated porphyrins, such as uroporphyrins and heptaporphyrins [17]. In our human population, we observed that levels of individual urinary porphyrins (uropophyrins, heptaporphyrins, coproporphyrins) did not increase with serum HCB concentrations. Even though our results contrast with the findings to be expected from experiments in animals [17], in general, they coincide with older studies in human populations (table 5) since no increase of uroporphyrins was observed in any of these studies. In addition, in contrast with animals, coproporphyrins (mainly CPIII) were lower in subjects with higher levels of HCB which agrees with an old study in workers from a chlorinated solvents plant [8]. Furthermore, neonates of Flix also showed a decrease of coproporhyrins in relation to HCB [18], although levels of urinary porphyrins during the first 10 days of life are highly variable [19], and results difficult to interpret. The negative association with coproporphyrins was not found in a cross-sectional study in the general population in Louisiana, USA [20], where plasma concentrations of HCB were positively correlated with levels of urinary coproporphyrin, though in a weak and crude way (correlation coefficient = 0.15. However, serum concentrations of HCB among these subjects were very low in contrast with spray workers from the same location among whom there was no association between HCB and individual coproporphyrins [7]. Finally, in a study comparing 9 smelter workers exposed to HCB and to octachlorostyrene with 18 non-exposed workers, CPIII was higher among the workers [21]. Only this latter study, in addition to the studies conducted in Flix, measured the porphyrin profile using a reliable method such as the high-pressure liquid chromatography. However, the authors did not report the levels of HCB, and comparisons were not adjusted for other variables related with porphyrins such as age and smoking.
Table 5

Studies on urinary porphyrins in human populations exposed to moderate levels of hexachlorobenzene (HCB).




Author year/country (ref)



Serum-HCB (range in ng/mL)






   Morley 1973/Australia [6]






only 1 worker with high UP

   Burns 1974/USA [7]







   Currier 1980/USA [8]





↓ CP if HCB > 200

   Selden 1999/Sweden [21]





↑ CPIII in E vs NE





   Ozalla 2002/Spain [18]








   Burns 1975/USA [20]






   This study/Spain






NA: not available. NS: no statistically significant difference. UP: uroporphyrins. CP, CPI and CPIII: coproporphyrins total, I and III. E/NE: number of subjects exposed/non-exposed

Epidemiological studies on porphyrins with other environmental agents are rare. The possible role of other halogenated compounds, such as dioxins (TCDD), in the disturbance of the porphyrin metabolism was proposed due to some case reports of PCT among workers [22]. However, this effect was mostly attributed to a concomitant exposure to HCB [22]. Recent epidemiological studies in human populations did not find any association of TCDD exposure with regard to urinary uroporphyrin or coproporphyrin levels [23, 24]. A negative association between arsenic concentration in urine and CPIII was found in 36 individuals from the general population in an area of Mexico with high levels of arsenic in drinking water compared with 31 non-exposed subjects [25]. In contrast with studies on HCB, a concomitant increase in uroporphyrins occurred. Also, in a crossectional study carried out in a convention of dentists, the 38 dentists with levels of total mercury higher than 20 μg/l had higher levels (twice) of urinary coproporphyrins than the 23 dentists with no detectable levels of mercury [26]. Mechanisms of action for these compounds, however, could be of a different nature than those related with HCB.

In accordance with our previous observation of an association of passive smoking with CPIII in neonates [18], active smoking is associated with an increase of porphyrins in the present study. In patients with intermittent porphyria, smoking was associated with induction of repeated acute attacks of porphyria [27]. This finding agrees with a possible indirect effect of smoke through a cytochrome P450 induction, since some P450 isoenzymes such as P4501A2s, which is affected by smoking, are involved in disturbances of porphyrin metabolism [28]. Recently it has been suggested that HCB should be classified as a dioxin-like compound that binds the Aryl hydrocarbon (Ah) receptor inducing hepatic cytochrome p4502B activity [29]. Why smoking is associated with an increase of CPIII while HCB was associated with a decrease of CPI and CPIII, without modifying uroporphyrin levels, is an intriguing problem to solve.

Overall, the epidemiological studies in human populations have to be considered with caution given their size, the methodology used to measure the porphyrin profile, the control of the effect of variables such as age and smoking and the difficulties in disentangling the individual pollutant effects from the pollution mixtures. A conclusion from such review is the lack of a common procedure in environmental studies of porphyria. In addition, porphyrin increases have been related with the multiple chemical sensitivity syndrome (MCS) [13]. However, there is currently no convincing evidence that MCS syndrome affects the haem synthesis [13]. Our findings confirm that it is premature and speculative to relate porphyrin increases with current environmental exposures.

The present results do not seem affected by a selection bias given that similar findings were observed both in the random and the enriched sample. Cross-sectional bias also seems improbable since exposure to HCB could not be determined by knowledge of levels of uroporphyrins and viceversa. A confounding effect due to an unmeasured variable seems also unlikely. Positive serology against virus C was only found in 4 of the subjects, and renal dysfunction was detected in a very small proportion [14]. A final explanation could be the presence of an error due to misclassification of uroporphyrins or HCB levels, non-differential, that led to the dilution of the association between HCB and uroporphyrins. Nevertheless, an error of this type should also have affected the association with smoking, while a positive association with smoking was found. In addition, in the present study porphyrin patterns and HCB levels were determined with the best current technology. These facts suggest that the effect of this misclassification error if any must be small and unlikely to explain the complete lack of porphyrin increase according to the categories of HCB.

The present study is the largest ever conducted, used a reliable method of measuring porphyrin patterns and incorporated analysis of cofactors. In addition, the population under study is specifically exposed to high levels of HCB (serum concentrations were around 20 times higher than in unexposed Europeans of the same age [10], and levels of other pollutants such as PCB, DDE or dioxins were within the range of most populations [9]).


The present results suggest that current levels of HCB are not associated with an increase of the individual uroporphyrins, and if anything are associated with a decrease of the coproporphyrins, which challenges the concept of a porphyrinogenic effect of environmental pollutants at current levels of exposure.



Porphyria Cutanea Tarda




Coproporphyrin I


Coproporphyrin III


Polychlorinated Biphenyls


Uroporphyrin I

Hepta I: 

Heptacarboxylporphyrin isomer I

Hepta III: 

Heptaporphyrin isomer III


Multiple Chemical Sensitivity


Uroporphyrin III



We thank Carlos Mazón MD and Antoni Verdú MD of the pediatric department of the Hospital of Móra d'Ebre for their collaboration. We are indebted to the participants for their altruism in participating, and also thank Luisa Alvarez MD for creatinine determinations.

Authors’ Affiliations

Respiratory and Environmental Research Unit, Institut Municipal d'Investigació Mèdica, Barcelona, Catalonia
Universitat Pompeu Fabra, Barcelona
Porphyria Unit. Department of Dermatology. Hospital Clinic. IDIBAPS, Faculty of Medicine, University of Barcelona. Villaroel
Department of Environmental Chemistry, ICER-CSIC, Barcelona. Jordi Girona Salgado


  1. Ockner RK, Schmid R: Acquired porphyria cutanea tarda in man and rat due to hexachlorobenzene intoxication [letter]. Nature. 1961, 189: 499-View ArticleGoogle Scholar
  2. Peters H, Cripps D, Gocmen A, Bryan G, Ertürk E, Morris C: Turkish epidemic hexachlorobenzene porphyria. A 30-year study. Ann N Y Acad Sci. 1987, 514: 183-190.View ArticleGoogle Scholar
  3. Dogramaci I: Porphyria turcica (cutaneous porphyria in southeastern Turkey): General considerations. Turk J Pediatr. 1962, 4: 129-131.Google Scholar
  4. Dogramaci I: Porphyrias and Porphyrin Metabolism with Special Reference to Porphyria in Childhood. Adv Pediatr. 1964, 13: 11-63.Google Scholar
  5. Mazzei ES, Mazzei CM: Porfiria por hexaclorobenzeno. Prensa Med Argen. 1972, 59: 1205-1211.Google Scholar
  6. Morley A, Geary D, Harben F: Hexachlorobenzene pesticides and porphyria. Med J Aust. 1973, 1: 565-Google Scholar
  7. Burns JE, Miller FM, Gomes E, Albert R: Hexaclorobenzene exposure from contaminated DCPA in vegetable spraymen. Arch Environ Health. 1974, 29: 192-194.View ArticleGoogle Scholar
  8. Currier MF, McClimans CD, Barna-Lloyd G: Hexachlorobenzene blood levels and the health status of men employed in the manufacture of chlorinated solvents. J Toxicol Environ Health. 1980, 6: 367-377.View ArticleGoogle Scholar
  9. Grimalt JO, Sunyer J, Moreno V, Amaral OC, Sala M, Rosell A, Anto JM, Albaiges J: Risk excess of soft-tissue sarcoma and thyroid cancer in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content. Int J Cancer. 1994, 56: 200-203.View ArticleGoogle Scholar
  10. Sala M, Sunyer J, Otero R, Santiago-Silva M, Camps C, Grimalt J: Organochlorine in the serum of inhabitants living near an electrochemical factory. Occup Environ Med. 1999, 56: 152-158.View ArticleGoogle Scholar
  11. Herrero C, Ozalla D, Sala M, Otero R, Santiago-Silva M, Lecha M, To-Figueras J, Deulofeu R, Mascaró JM, Grimalt J, Sunyer J: Urinary Porphryin Excretion in a Human Population Highly Exposed to Hexachlorobenzene. Arch Dermatol. 1999, 135: 400-404. 10.1001/archderm.135.4.400.View ArticleGoogle Scholar
  12. Santos JL, Grandal M, Fontanellas A, Morán MJ, Enriquez de Salamanca R: Prevalencia de porfiria cutánea tarda en Madrid y asociación entre la porfirinuria y el consumo de etanol. Med Clin (Barc). 1996, 107: 614-616.Google Scholar
  13. Daniell WE, Stockbridge HL, Labbe RF, Woods JS, Anderson KE, Bissell DM, Bloomer JR, Ellefson RD, Moore MR, Pierach CA, Schreiber WE, Tefferi A, Franklin GMl: Environmental chemical exposures and disturbances of haeme synthesis. Environ Health Perspect. 1997, 105 (Suppl 1): 37-53.View ArticleGoogle Scholar
  14. Sala M, Sunyer J, Otero R, Santiago-Silva M, Ozalla D, Herrero C, To-Figueras J, Kogevinas M, Anto JM, Camps C, Grimalt J: Health effects of chronic high exposure to hexachlorobenzene in a general population sample. Arch Environ Health. 1999, 54: 102-109.View ArticleGoogle Scholar
  15. To-Figueras J, Sala M, Otero R, Barrot C, Santiago-Silva M, Rodamilans M, Herrero C, Grimalt J, Sunyer J: Metabolism of hexachlorobenzene in humans: Association between serum levels and urinary metabolites in a highly exposed population. Environ Health Perspect. 1997, 105: 78-83.View ArticleGoogle Scholar
  16. Rossi E, Curnow DH: HPLC of small Molecules. – A practical approach. In the Practical Approach. Series. Edited by: CK Lim. 1986, IRL Press Oxford, 261-303.Google Scholar
  17. Elder GH: Porphyrins in Human Diseases. 1 st Int. Porphyrin Meet. Freiburg. (Karger, Basel 1976). 1975, 424-431.Google Scholar
  18. Ozalla D, Herreo C, Ribas-Fitó N, To-Figueras J, Toll A, Sala M: Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene. Environ Health Perspect. 2002, 110: 205-209.View ArticleGoogle Scholar
  19. Rocchi E, Balli F, Gibertini P, Trenti T, Pietrangelo A, Cassanelli M: Coproporphyrin excretion in healthy newborn babies. J Pediatr Gastroenterol Nutr. 1984, 3: 402-407.View ArticleGoogle Scholar
  20. Burns JE, Miller FM: Hexachlorobenzene contamination: its effect in a Lousisiana population. Arch Environ Health. 1975, 30: 44-48.View ArticleGoogle Scholar
  21. Sélden A, Floreus Y, Bodin LS, Westberg HB, Thunell S: Porphyrin status in aluminium foundry workers exposed to hexachlorobenzene and ocatachlorostyrene. Arch Environ Health. 1999, 54: 248-253.View ArticleGoogle Scholar
  22. Jones RE, Chelsky M: Further discussion concerning porphyria cutanea tarda and TCDD expoure. Arch Environ Health. 1986, 41: 100-103.View ArticleGoogle Scholar
  23. Calvert GM, Sweeney MH, Fingerhut M, Hornung RW, Halperin WE: Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Ind Med. 1994, 25: 559-571.View ArticleGoogle Scholar
  24. Jung D, Konietzko J, Reill-Konietzko G, Muttray A, Zimmermann-Holz HJ, Doss M: Porphyrin studies in TCDD-exposed workers. Arch Toxicol. 1994, 68: 595-598. 10.1007/s002040050120.View ArticleGoogle Scholar
  25. García-Vargas G, Del Razo LM, Cebrián MA, Albores A, Ostrosky-Wegman P, Montero R: Altered urinary porphyrin excretion in a human population chronically exposed to arsenic in México. Hum Exp Toxicol. 1994, 13: 839-847.View ArticleGoogle Scholar
  26. Woods JS, Martin MD, Naleway CA, Echeverra D: Urinary porphyrin profiles as a biomarker of mercury exposure: studies on dentists with occupational exposure to mercury vapor. J Toxicol Environ Health. 1993, 40: 235-246.View ArticleGoogle Scholar
  27. Lyp GYH, McColl KEL, Goldberg A, Moore MR: Smoking and recurrent attacks of acute intermittent porphyria. BMJ. 1991, 302: 507-View ArticleGoogle Scholar
  28. Sinclair PR, Gorman N, Walton HS, Bement WJ, Dalton TP, Sinclair JF, Smith AG, Nebert DW: CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron. Toxicol appl pharmacol. 2000, 162: 60-67. 10.1006/taap.1999.8832.View ArticleGoogle Scholar
  29. van Birgelen APJM: Hexachlorobenzene as possible major contributor of the dioxin-activity of human milk. Environ Health Perspect. 1998, 106: 683-688.View ArticleGoogle Scholar
  30. Pre-publication history

    1. The pre-publication history for this article can be downloaded from here:


© Sunyer et al; licensee BioMed Central Ltd. 2002

This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.